Startup promises face time with IBM's Watson

Share this article:

Digital health startup Welltok said yesterday that it had received $22.1 million in Series C funding from IBM and Qualcomm Ventures' life fund portfolio.

Welltok is currently developing a health optimization platform, CafeWell. The company says the platform helps population health managers organize "the expanding ecosystem of health and wellness solutions," like apps and tracking devices and delivers a consumer platform that offers incentives for certain activities. It cites a premium reduction for lowering your body mass index (BMI) as an example.

Welltok stated that it plans to use the additional funding to harness IBM's Watson "to address consumer questions about their health conditions and activities through personalized dialogue and guide them via Intelligent Health Itineraries," as well as expand CafeWell's solutions for health plans, ACOs, and add new partners "that are creating communities, innovative condition management, and wellness programs, tracking devices and applications."

SVP of the IBM Watson Group Mike Rhodin stated, "This investment and partnership represent IBM's dedication to fueling innovation that improves lives and our mission to advance the field of health care into the new era of cognitive computing."

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

FDA wants Alexion to clean up

FDA inspectors have cited the manufacturer of the rare-disease drug Soliris (eculizumab) for poor manufacturing practices.

Painkiller maker Acura gets NIH grant

The $300,000 grant will go towards an abuse-deterrent technology.

Biologics have higher psoriatic arthritis adherence

A study of psoriatic arthritis patients found greater adherence among patients whose initial treatment was a biologic, compared to those who started with a non-biologic treatment.